Here's Why TherapeuticsMD Stock Is Rocketing Higher Today
Shares of TherapeuticsMD (NASDAQ: TXMD), a women's healthcare company, are on the rise following good news for its contraceptive device Annovera. Investors expecting more predictable cash flows have driven the stock 56% higher as of 1:06 p.m. EDT on Tuesday.
Annovera's a reusable contraceptive ring that contains two synthetic hormones -- segesterone acetate and ethinyl estradiol -- that prescription contraceptives have been using for a long time. Annovera remains inserted for three weeks and releases these two ingredients slowly before women need to remove and store the device for a week.
Image source: Getty Images.
Source Fool.com
